(firstQuint)Assess the Immunogenicity of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine.

 Test groups: 2 groups (60 subjects/group).

 10Pn-PD-DiT group receiving GSK Biologicals' 10-valent pneumococcal conjugate vaccine + DTPa-HBV-IPV/Hib; Control group receiving Prevenar + DTPa-HBV-IPV/Hib.

 Assess the Immunogenicity of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine@highlight

Evaluate the immune response of GSK Biologicals' 10-valent pneumococcal conjugate vaccine one month after completion of a 3-dose primary vaccination course administered at 2, 3, 4 months of age